Cargando…

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice

BACKGROUND: The tumor immunosuppressive microenvironment represents a major obstacle to an effective tumor-specific cellular immune response. METHODS: In the present study, the counterbalance effect of a novel metronomic chemotherapy protocol on such an immunosuppressive microenvironment was evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tagliamonte, Maria, Petrizzo, Annacarmen, Napolitano, Maria, Luciano, Antonio, Rea, Domenica, Barbieri, Antonio, Arra, Claudio, Maiolino, Piera, Tornesello, Marialina, Ciliberto, Gennaro, Buonaguro, Franco M., Buonaguro, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766679/ https://www.ncbi.nlm.nih.gov/pubmed/26911136 http://dx.doi.org/10.1186/s12967-016-0812-1

Ejemplares similares

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
por: Petrizzo, Annacarmen, et al.
Publicado: (2017)

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
por: Petrizzo, Annacarmen, et al.
Publicado: (2018)

Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012)

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)

HPV monitoring in kidney transplanted patients
por: Buonaguro, Franco M, et al.
Publicado: (2012)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
por: Buonaguro, Luigi, et al.
Publicado: (2008)

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders
por: Buonaguro, Luigi, et al.
Publicado: (2010)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
por: Petrizzo, Annacarmen, et al.
Publicado: (2021)

Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles
por: Ponterio, Eleonora, et al.
Publicado: (2013)

Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders
por: Petrizzo, Annacarmen, et al.
Publicado: (2012)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
por: Visciano, Maria Luisa, et al.
Publicado: (2012)

Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023)

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Functional characterization of biodegradable nanoparticles as antigen delivery system
por: Petrizzo, A., et al.
Publicado: (2015)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens
por: Buonaguro, Franco Maria, et al.
Publicado: (2015)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
por: Tagliamonte, Maria, et al.
Publicado: (2012)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
por: Tagliamonte, M, et al.
Publicado: (2009)

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma
por: De Giorgi, Valeria, et al.
Publicado: (2009)

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation
por: Aricò, Eleonora, et al.
Publicado: (2005)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2018)

Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2018)

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
por: Visciano, M, et al.
Publicado: (2009)

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
por: Tornesello, Maria Lina, et al.
Publicado: (2016)

Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
por: Starita, Noemy, et al.
Publicado: (2018)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qj5c14l74cu64fblmnlaif4tj2